Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom

Assessing the Health and Economic Outcomes of a 9-Valent HPV Vaccination Program in the United Kingdom

**Background:** The United Kingdom (UK) switched from using the 4-valent human papillomavirus (HPV) vaccine (Gardasil®) to the 9-valent vaccine (Gardasil 9®) in 2021. **Objective:** To estimate and compare the health and economic outcomes of 2 HPV vaccination programs in the UK targeting girls and...

Full description

Saved in:
Bibliographic Details
Main Authors: Kwame Owusu-Edusei, Cody Palmer, Olga Ovcinnikova, Giampiero Favato, Vincent Daniels
Format: Article
Language:English
Published: Columbia Data Analytics, LLC 2022-06-01
Series:Journal of Health Economics and Outcomes Research
Online Access:https://doi.org/10.36469/001c.34721
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items